Shiyou Wei
Overview
Explore the profile of Shiyou Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng L, Yan H, Jiang W, Qin H, Dai J, Zhang Y, et al.
Med
. 2025 Feb;
:100574.
PMID: 39892382
Background: Perioperative treatment with toripalimab combined with chemotherapy was efficacious and safe in resectable stage II-IIIA non-small cell lung cancer (NSCLC); however, little is known about whether this treatment regimen...
2.
Duan H, Ren J, Wei S, Yang Z, Li C, Wang Z, et al.
Genome Med
. 2024 Nov;
16(1):138.
PMID: 39593114
Background: Lung cancer brain metastases (LC-BrMs) are frequently associated with dismal mortality rates in patients with lung cancer; however, standard of care therapies for LC-BrMs are still limited in their...
3.
Xu J, Ling D, Xu Q, Sun P, Wei S, Gao L, et al.
Clin J Pain
. 2024 Oct;
41(1).
PMID: 39475834
Objectives: The double-point serratus anterior plane block (SAPB) covers more area, including the axilla, than the single-point approach, potentially offering better pain relief after modified radical mastectomy (MRM). The objective...
4.
Wei S, Du K, Lan H, Yang Z, Deng Y, Wei Z, et al.
bioRxiv
. 2024 Sep;
PMID: 39314469
Statement Of Translational Relevance: This study paves the way for the creation of innovative therapeutic strategies, aimed at subverting resistance to immune checkpoint blockade (ICB) therapies in metastatic melanoma patients....
5.
Gu X, Wei S, Lv X
Signal Transduct Target Ther
. 2024 Sep;
9(1):226.
PMID: 39218931
The primary reason for high mortality rates among cancer patients is metastasis, where tumor cells migrate through the bloodstream from the original site to other parts of the body. Recent...
6.
Wang T, Wang Z, Jie H, Liu C, Wei S, Liao H, et al.
Transl Lung Cancer Res
. 2024 Aug;
13(7):1530-1543.
PMID: 39118884
Background: Mediastinal station 8 lymph node dissection (8LND) is recommended by guidelines but not routinely performed in real world clinical practice. This study aimed to investigate the effect of 8LND...
7.
Wang Q, Shen J, Luo S, Yuan Z, Wei S, Li Q, et al.
Respir Res
. 2024 Jul;
25(1):276.
PMID: 39010105
Background: The pathogenesis of acute lung injury (ALI) involves a severe inflammatory response, leading to significant morbidity and mortality. N6-methylation of adenosine (m6A), an abundant mRNA nucleotide modification, plays a...
8.
Yuan Z, Wang Q, Tan Y, Wei S, Shen J, Zhuang L, et al.
Int Immunopharmacol
. 2024 Jun;
138:112548.
PMID: 38944949
Background: Acute lung injury (ALI) is manifested by increased blood vessel permeability within the lungs and subsequent impairment of alveolar gas exchange. Methylprednisolone (MP) is commonly used as a treatment...
9.
Chen Z, Wei S, Yuan Z, Chang R, Chen X, Fu Y, et al.
Immun Inflamm Dis
. 2024 May;
12(5):e1279.
PMID: 38780016
Objective: Sepsis is an organ malfunction disease that may become fatal and is commonly accompanied by severe complications such as multiorgan dysfunction. Patients who are already hospitalized have a high...
10.
Wei S, Ling D, Zhong J, Chang R, Ling X, Chen Z, et al.
Mol Med
. 2024 Apr;
30(1):53.
PMID: 38649840
Objective: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are associated with significant mortality rates. The role of Fcgr2b in the pathogenesis of ALI/ARDS is not fully elucidated....